Lotus Pharmaceuticals, Inc. (OTCBB: LTUS)
BEIJING, May 4, 2007 (PRIME NEWSWIRE) — Lotus Pharmaceuticals, Inc. (OTC BB:LTUS.OB – News) proudly announced that its Director Mel Rothberg has been honored by The Greater Miami Chamber of Commerce’s Healthcare & Bioscience Committee. Mr. Rothberg was chosen as one of the 2007 Health Care Heroes(r) whose acts of heroism represent a display of dedication to excellence in their area of expertise beyond the scope of their jobs.
In the field of Bio Medical, Mr. Mel Rothberg is the 2007 recipient. Mr. Rothberg has, over the last 30 years, participated in the development of the South Florida bioscience industry and is presently Chairman of Bioflorida’s South Florida Bioscience Consortium. He has held executive positions in the medical device, information technology and biopharmaceutical sectors. Currently, he is Chairman and CEO of Advanced Processing and Imaging, CEO of Dharma Biomedical and CEO of Rothberg Associates, Inc.
As a founding director on the Lotus Board of Directors, Mr. Rothberg is committed to assisting in the growth and expansion of the Beijing-based pharmaceutical. “Lotus Pharmaceuticals has demonstrated remarkable growth in the Chinese healthcare marketplace. I look forward to assisting Lotus in identifying additional growth opportunities that builds on the solid entrepreneurial foundation led by Dr. Liu and his team,” commented Mr. Rothberg.
About Lotus Pharmaceuticals, Inc.
Lotus Pharmaceuticals, Inc. (“Lotus”) owns and operates Liang Fang Pharmaceutical, Ltd. (“Liang”) and En Zhe Jia Shi Pharmaceutical, Ltd. (“En Zhe”), two Chinese pharmaceutical companies located in Beijing. Liang and En Zhe form a large comprehensive enterprise, which deals in an integration of the production, trade, sales and marketing of pharmaceuticals. Together, they possess some of the most advanced pharmaceutical-production equipment used in China, workshops authenticated by the National GMP, a suite of various medicines produced by Liang and/or En Zhe (together, “Lotus East”), and a large number of high-tech personnel. Lotus East has business and office facilities of 2,000 square meters and a warehouse of 1,000 square meters. Lotus East performs scientific research on new medicines, and the production, wholesale and retail sale of medicines. For more information, visit http://www.LotusEast.com.
Contact:
Lotus Pharmaceuticals, Inc.
Mr. Adam Wasserman, CFO
(877) 801-0344
Fax: (954) 337-2204
info@LotusEast.com
Source: Lotus Pharmaceuticals Inc.
View the StockGuru Profile for Lotus Pharmaceuticals:
http://www.stockguru.com/profiles/ltus/
We Invite you to Visit the All New StockGuru Blog!
Here you will find updates on all our covered companies, including Profiled Companies and StockGuru Picks.
Click HERE to visit the Blog, or go to:
http://stockguru.com/blog/
StockGuru.com is owned and operated by Pentony Enterprises LLC, 9555 Lebanon Road, Suite 103, Frisco, Texas 75035. Telephone: (469) 252-3030. Web: StockGuru.com. Email: Publisher@stockguru.com. Disclosure: Pentony Enterprises LLC was compensated $10,000 directly from the company for profile coverage. Pentony Enterprises LLC is not a registered investment adviser or broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site aresuitable or advisable for any person or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
